Upcoming Allied Market Research
Anti-glaucoma Management Market

Anti-glaucoma Management Market

by Drug Class (Prostaglandin Analogs, Beta-Blockers, Alpha Adrenergic Agonists, Carbonic Anhydrase Inhibitors, Combination Drugs, Others), by Indication (Open-angle Glaucoma, Angle Closure Glaucoma, Others) and by End User (Hospitals and Clinics, Surgical Centers, Diagnostic Centers, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

Report Code: A11533
Pages: NA
Jul 2023 | 1178 Views
Author(s) : Onkar S
Tables: NA
Charts: NA
  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.



Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Anti-glaucoma Management Market

Request Now !

Anti-glaucoma Management Market Overview:

Glaucoma is a group of eye conditions that damages the optic nerve, which is vital for good vision. The damage is often caused when there is abnormal pressure on the eyes. Glaucoma is one of the major causes of blindness in people aged above 60 years. It may occur at any age but it is known to be more common in adults. The change in vision due to glaucoma is gradual, which is why a huge change in vision is not seen until the condition is at an advanced stage. The vision loss due to glaucoma cannot be recovered, it is, therefore, important to have regular eye exams that include the measurement of eye pressure; this will help in early-stage diagnosis.


COVID-19 Impact Analysis

COVID-19 is an infectious disease that originated in the Hubei province of the Wuhan city in China in late December. The highly contagious disease, caused by a virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is transmitted from human to human. Since the outbreak in December 2019, the disease has spread to almost 213 countries around the globe with the World Health Organization declaring it a public health emergency on March 11, 2020.

Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicine supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are facing a shortage of these drugs. Thus, the pharmaceutical and biotechnology industry industries are expected to witness significant growth in the future, owing to the demand for vaccines and treatment drugs for COVID-19. This, in turn, is expected to have a significant impact on the anti-glaucoma management market.

Top Impacting Factors

Increase has been witnessed in the prevalence of glaucoma among the geriatric population. Increase in screen time of various gadgets such as smartphones and laptops among this population is further aiding the rising cases of glaucoma. According to the International Agency for the Prevention of Blindness (IAPB), around 80 million people across the world suffer from glaucoma.

There are numerous products under development for glaucoma treatment that can accelerate the growth of the anti-glaucoma management market. On May 15, 2019, Aerie Pharmaceuticals announced the submission of a new drug application (NDA) to the FDA for roclatan, which is a fixed-dose combination for glaucoma therapy.

However, there have been many drugs recalls for drugs that were launched as part of the glaucoma therapy program. For instance, Allergan had to call its lot of lumigan and combigan due to failure to meet purity qualifications and regulatory standards.

High cost of the therapies and treatment for glaucoma further hinder the growth of the anti-glaucoma market in developing economies. The research and development activities for glaucoma therapies need more extension for companies to launch better products.

Key Market Trends

There has been an increase in prostaglandin analog research, which led to a shift toward the acceptance of this drug class among the patients suffering from glaucoma. In addition, this drug class promises lower side effects and better efficiency as compared to other therapeutic products and treatment options.

Allergan and Novartis AG are focused on the distribution and manufacturing of prostaglandin analogs lumigan and travatan, respectively. A strong focus on mergers and partnerships as well as increase in adoption of product developments are some of the vital strategies that have been adopted by the key players in the anti-glaucoma management market.

In May 2020, the strategies acquisition of Allergan was completed by AbbVie Inc. This acquisition helped AbbVie Inc. to become one of the leaders in the market.

In December 2019, the launch of AIBETA, a product from Senju Pharmaceutical Co., Ltd. was announced. AIBETA is a combination drug to manage hypertension and glaucoma in Japan.

Key Benefits of the Report

  • This study presents the analytical depiction of the anti-glaucoma management industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with a detailed analysis of the anti-glaucoma management market share.
  • The current market is quantitatively analyzed to highlight the anti-glaucoma management market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed anti-glaucoma management market analysis depending on competitive intensity and how the competition will take shape in the coming years.

Questions Answered in the Global Anti-glaucoma Management Market Report

  • Which are the leading players active in the anti-glaucoma management market?
  • How is each segment of the market expected to grow during?
  • What are the adoption trends for anti-glaucoma management in emerging economies and established economies across the world?
  • What are the current trends that will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities of the market?
  • What future projections would help in taking further strategic steps?
  • What is anti-glaucoma management?
  • What is anti-glaucoma management market prediction in the future?
  • What are the current trends and predicted trends?

Anti-glaucoma Management Market Report Highlights

Aspects Details
By Drug Class
  • Prostaglandin Analogs
  • Beta-Blockers
  • Alpha Adrenergic Agonists
  • Carbonic Anhydrase Inhibitors
  • Combination Drugs
  • Others
By Indication
  • Open-angle Glaucoma
  • Angle Closure Glaucoma
  • Others
By End User
  • Hospitals and Clinics
  • Surgical Centers
  • Diagnostic Centers
  • Others
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (Germany, France, UK, Italy, Spain, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
Key Market Players SIFI S.p.A, Novartis AG, Allergan Plc, Merck & Co. Inc., Inotek Pharmaceuticals Corp., Teva Pharmaceutical Industries Ltd., Santen Pharmaceutical Co. Ltd., Aerie Pharmaceuticals Inc., Bausch & Lomb Incorporated (Bausch Health Companies Inc.), Pfizer Inc.

Loading Table Of Content...

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.


Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now

Purchase Full Report of
Anti-glaucoma Management Market

Start reading.
This Report and over 54,639+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820
  • Restricted to one authorized user
  • One print only
  • Available in
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540
  • Limited to five authorized users
  • Print upto five copies
  • Available in
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Enterprise

  • $9,870
  • Unlimited
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Library

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
  • Company Profiles
  • Newly Added Content Access
  • 10 PDF
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD


Why Allied Market Research?


Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of scope of the report to exactly meet your needs


Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of scope of the report to exactly meet your needs


Targeted market view to provide pertinent information and save time of readers